Back
BioAge Labs, Inc. 10K Form
Buy
52
BIOA
BioAge Labs, Inc.
Last Price:
$10.49
Seasonality Move:
-80.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIOA News And Ratings
See the #1 stock for the next 7 days that we like better than BIOA
BIOA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-16.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.74 |
| Price / Book: | 1.19 |
Profitability
| EPS (TTM): | -2.11410 |
|---|---|
| Net Income (TTM): | $-75.8M |
| Gross Margin: | $-167K |
| Return on Equity: | -24.89% |
| Return on Assets: | -22.74% |
BioAge Labs, Inc. Earnings Forecast
Key BioAge Labs, Inc. Financial Ratios
-
Per Share Earnings over the last 8 years have been positive in 3 years.
BioAge Labs, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | BIOA |
| CUSIP: | 09072Q |
| Website: | bioagelabs.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 11.87 |
| Quick Ratio: | 11.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BIOA Technical Analysis vs Fundamental Analysis
Buy
52
BioAge Labs, Inc. (BIOA)
is a Buy
Is BioAge Labs, Inc. a Buy or a Sell?
-
BioAge Labs, Inc. stock is rated a BuyThe current BioAge Labs, Inc. [BIOA] share price is $10.50. The Score for BIOA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.